Articol Greabu


Maria Justina Roxana Virlan1a, Bogdan Calenic1b, Catalin Zaharia 2c, Maria Greabu1d*

1 Department of Biochemistry, Faculty of Dental Medicine, „Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
2 Advanced Polymer Materials Group, Faculty of Applied Chemistry and Materials Science, University Politehnica of Bucharest, Bucharest, Romania

a.DDS, PhD Student
b.DDS, PhD, Teaching Assistant
c.PhD, Associate Professor
d.PhD, Professor, Head of Department


*Corresponding author:

Professor Maria Greabu, PhD, Head of Department, Department of Biochemistry, Faculty of Dental Medicine, „Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
8 Blvd. Eroii Sanitari, Sector 5, RO-050474, Bucharest, Romania
Tel: +40721274932, Fax: +4021 3110984 ; e-mail:



Silk fibroin is an organic polymer  isolated from cocoons silk fibers. Recently it was studied as a substrate for tissue engineered cartilage, bone , ligaments, nerves, cornea  and also for drug delivery applications. The current review focuses on recent advance in silk fibroin and its potential uses in regeneration therapies, mainly in the dental field. Data extraction was carried out according to the standard Cochrane systematic review methodology and the following databases were used: PubMed, Google Scholar, Medline and the Google library. From the 151 related articles that were critically assessed, only 57 articles were included in the critical appraisal. There is evidence that silk fibroin is a biocompatible polymer and has been proven to be be cytocompatible with a wide variety of cells. Composite silk fibroin with hydoxyapaptite, bioglass, gold or silica can be used in a variety of applications.  Regenerative dentistry may profit from the silk fibroin due to possible future uses in implant therapy, mineralized tissue formation or healing of the wounds of the buccal mucosa.

Keywords: silk fibroin, organic polymer, bone regeneration, drug delivery, wound healing

1.Silk fibroin


Silk represents the strongest and toughest naturally occuring polymer material  (1) . Silk from silkworms and orb-weaving spiders have impressive mechanical properties in addition to environmental stability, biocompatibility, controlled proteolytic biodegradability, morphological flexibility and the ability for the aminoacid side charge modification  to immobilize growth factors (2). Silk fibroin is a structural protein isolated from cocoons silk fibers of the silkworm Bobymex mori  (2, 3) and it has a long history of use in clinical applications  as sutures (2).Recently it was also studied   as a substrate for tissue engineered cartilage, bone(4),(5),(6), ligaments  and also for drug delivery applications (7)  (8-10).

1.1.Silk fibroin in drug delivery vehicles

A wide range of polymeric materials  have been investigated for use as drug delivery matrices, including biodegradable synthetic polymers such as PLGA, and natural polymers like collagen (3).The addition of silk seemed to improve the controlled release proprieties. It was shown, that as the  crystalline content of silk increased ,the slower  was the release of the encapsulated protein(7). Other strategies to fine-tune the release from silk fibroin matrices include the embedment of drug loaded micro- or nanoparticles or the coating of micro- or nanoparticles with silk fibroin films (11). Also silk coating of liposomes loaded with the anti-tumor drug Emodin significantly retarded drug release without affecting the drug efficacy (9).Moreover silk microspheres could offer unique options as drug delivery carriers,given the fact that silk microspheres  are much smaller than PLGA microspheres (3).

 1.2 Silk fibroin scaffolds

Mimicking the natural extracellular matrix is one of the critical and challenging technological barriers, for which scaffold engineering has become a prime focus of research within the field of tissue engineering (12). Silk fibroin could act as a scaffold material, a substrate on which cells can thrive and receive stimuli such as growth factors that guide the differentiation process of cells (7), through controlled drug delivery. The compressive modulus of gas foamed silk fibroin scaffolds was superior as compared to scaffolds prepared from collagen, chitosan, PLGA and PLLA, materials that are intensively studied as scaffolds materials (13).

A variety of cells were cultured on fibroin scaffolds and maintained their viability. Endothelial cells were cultured on the silk fibroin  and the cells attached and proliferated, forming after a week microvessel-like structures (14). Also a silk fibroin  film and BMP-2 induced osteogenic differentiation of human bone marrow stromal cells (5). Additionally, amniotic fluid stem cells were also seeded on silk bioengineered constructs and were able to differentiate into osteoblast cells in vivo (15). In vitro culture in chondro- or osteo-inductive media showed that  silk non-mulberry constructs pre-seeded with human bone marrow stromal cells exhibited prominent areas of the neo tissue containing chondrocyte-like cells, whereas mulberry constructs pre-seeded with human bone marrow stromal cells formed bone-like nodules (16).

Silk fibroin nanofibers seem to be cytocompatible with human keratinocytes and fibroblasts (4, 6).Three forms of silk fibroin  matrices, woven (microfiber), non-woven (nanofiber), and film form, were used to test the compatibility with cell cultures of normal human oral keratinocytes   by examining the cell attachment and spreading of cells (17-19). The results indicated that the silk fibroin  nanofiber matrix may be more preferable than silk fibroin film and silk fibroin microfiber matrices for biomedical applications, such as wound dressings and scaffolds for tissue engineering(17) (18).

Moreover composite silk scaffolds, such as nanostructured biocomponent silk fibroin/chitin scaffolds proved to be cytocompatible  in interaction with  human epidermal keratinocytes (20). Osteoblasts were cultivated on silk fibroin/nano-hydroxyapatite scaffolds in vitro  and demonstrated excellent cytocompatibility as well as improved viability of osteoblasts (21).

Besides hydroxyapatite, collagen was incorporated into silk fibroin and  therefore  biomimetic bone substitutes of of collagen-silk fibroin/hydroxyapatite were fabricated (22).This bi-template material exhibited good biocompatibility and stimulated the bone marrow mesenchymal  stem cells to differentiate into the osteoblast cell lineage (22) .

1.3.Biocompatibility of silk fibroin

Being a protein,biodegradation of silk fibroin predominantly occurs through proteolytic enzymes,with non-toxic degradation products and unproblematic degradation in vivo. Silk scaffolds have low immunogenicity, when the immunogenic and glycosylated proteins are separated  (23). The use of silk fibroin films in wound repair led to significantly lower distribution of inflammatory neutrophils than in controls, with animal models (24), while the implantation of a silk fibroin scaffold subcutaneously in mice led to a mild inflammatory reaction that disappeared after 12 weeks (25). No evidence of any inflammatory reaction was seen when a nanofiber silk fibroin membrane was used for 12 weeks in rabbit calvarial defects (26) .

2.1 Applications of silk fibroin

Due to its ease of processing, excellent biocompatibility, remarkable mechanical properties and tailorable degradability, silk fibroin has been explored for fabrication of various articles such as films, porous matrices, hydrogels, nonwoven mats and has been investigated for use in various tissue engineering applications, including bone, tendon, ligament, cartilage, skin, liver, trachea, nerve (27), cornea (28), eardrum, dental, and bladder (12).

Because silk fibroin can be gelatinized and still retain its biocompatibility and permeability,it can be used in a variety of applications (29). Silk fibroin scaffolds were used in wound-healing processes (2) (30). Silk fibroin gel containing  electrically polarized hydroxyapatite is an effective wound dressing and effectively advanced the maturation of fibroblasts porcine cells (29). Moreover the addition of hydroxyapatite or polarized hydroxyapatite to the silk fibroin scaffolds  improved the wound-healing properties, enhancing the migration of the endothelial cells, and so the number of migrated cells was 1.5 times larger than on the silk fibroin scaffold alone (30).

So far, the main focus of silk fibroin drug delivery systems has been on tissue regeneration applications (11). Other strategies to fine-tune the release from silk fibroin matrices comprise the embedment of drug loaded micro- or nanoparticles or the coating of micro- or nanoparticles with silk fibroin films(11). For instance, growth factor loaded silk fibroin  scaffolds were suggested for the tissue engineering of bone and cartilage, as well as for vascular and nerve regeneration devices and wound healing products. Moreover, silk fibroin matrices were proposed for oral, transmucosal and ocular drug delivery (11).

Silk fibroin could be also used in nerve regeneration techniques  and could be helpful in restoring motor function and preventing abnormal sensations after nerve injury (27). A nerve guidance conduit using electrospun silk fibroin was implanted in a 10-mm defect of the sciatic nerve in rats and the immunostaining analysis showed the formation inside the electrospun silk fibroin  of  well myelinated nerve fibres stained with axonal neurofilament and myelin basic protein (27).

Scaffolds of silk fibroin  were used for ligament tissue engineering applications(31)   (32). Mesenchymal stem cells were seeded on a hybrid scaffold, comprised of knitted silk fibroin and aligned silk fibroin electrospun fibers, and led to the expression and production of ligament-related proteins (32).

2.2 Silk fibroin in bone regeneration

Silk fibroin scaffold may be a good substitute for bone regeneration with better results  than a commercially available polylactic acid scaffold (33). In vitro study showed that silk fibroin led to increase activity of the obsteoblasts than polylactic acid, while the in vivo tests revealed that  the silk fibroin scaffold regenerated 78.30% of the original bone volume, while the polylactic acid implantation led to only 49.31% bone formation in rats (33). Also silk fibroin hydrogels injected in critical-sized defects in rabbits resulted in greater trabecular bone volume and thickness,significantly higher mineral and rate of bone formation  when compared to PLGA – copolymer of polylactic-polyglycolid acid (34).

Not only scaffolds, but also silk fibroin membranes proved bone regeneration abilities in animal studies (35). Silk fibroin nanofiber membranes were implanted in calvarial defects of rabbits for guided bone regeneration and resulted in complete healing with new bone at 12 weeks (26). After one month implantation of silk-fibroin subcutaneously in mice the three-dimensional soft tissue augmentation was stable, and histologic analysis revealed revascularization of the area through the biomaterial (25). In another animal study on rabbits, low-molecular-weight silk fibroin with Choukroun platelet-rich fibrin were used and   led to 59.83 ± 10.92%  new bone formation, compared to 49.86 ± 7.49% in the control group, while the  tissue mineral density was slightly increased (36).

Also small fragments of silk fibroin are able to increase the expression of osteoblastogenic genes and DNA microarray results showed  that alkaline phosphatase collagen type-I alpha-1, fibronectin, and transforming growth factor-beta1 expressions significantly increased (37).

Silk fibroin sponges were used to support orthopedic regeneration using  fibrin gels loaded with growth factors and  human adipose -derived mesenchymal stem cells (38). This construct had angioinductive, as well as osteoinductive abilities, proven by the the deposition of bone matrix proteins, alkaline phosphatase activity and calcium deposition, along with the formation of vascular networks, evidenced by endothelial cell surface markers (38).

Aquous-based silk fibroin scaffolds with plasma irradiation were succesfully tested in 48 femur critical size defects and led to the formation of new bone around the scaffolds (39). The introduction of plasma helped to change the hydrophobic nature into hydrophilic (39).  Moreover the immunohistochemical examination revealed the increased expression pattern in a set of osteoblast specific genes (TGF-β, TGF-β type III receptor, Runx2, type I collagen and osteocalcin)(39).

Silk fibroin scaffolds of different sizes and osteogenic cells seeded were used in different experiment to study  the differentiation of the human mesenchymal stem cells  along the osteoblastic lineage (40) (41). Silk fibroin scaffolds seeded with human stem cells showed good results in bone regeneration in animal studies (42). A study on cranial bone defects in rats used silk fibroin scaffolds seeded with  human stem cells from dental pulp and amniotic fluid stem cells. After 4 weeks of implantation mature bone correction with higher bone amount produced by the human amniotic stem cells was observed (42). Also silk scaffolds seeded with human mesenchymal stem cells predifferentiated in a osteogenic medium, seemed to promote bone formation in cranial defects in mice (43). Furthermore, silk scaffolds with human mesenchymal stem cells that had previously been differentiated along an osteoblastic lineage in vitro, were implanted in femur defects in rats, and resulted in an osteoinductive effect. The defects were completely bridged with a callus on the outside and around 30% newly formed woven bone tissue inside the defect (1). According to a study that investigated the human bone marrow derived mesenchymal stem cells, the mineralization on silk fibroin scaffolds with pores of 112-224 μm diameter was most efficient with an initial cell pre-culture period of 9 days (41).

By biomimetic strategy, apatite-coated porous biomaterial based on silk fibroin scaffolds  might provide an enhanced osteogenic environment for bone-related outcomes (44). Autologous bone marrow stromal cells seeded on apatite-silk fibroin scaffold managed to completely repair the bony defects in a mandibular canine model(44). However, when silk fibroin  scaffold or apatite-silk fibroin were used alone the bony defects remained in the centre with undegraded silk fibroin and fibrous connective tissue(44), showing the boosting of the regeneratory effect when bone marrow stromal cells were added.

However, silk is not an osteogenic material and has a compressive stiffness significantly lower than that of native bone (45) . Hydroxyapatite (HA)-silk fibroin scaffold   were  designed to induce and support the formation of mineralized bone matrix by human mesenchymal stem cells enhancing the formation of tissue engineered bone by two mechanisms: through osteoconductivity of the material leading to increased bone matrix production, and by providing nucleation sites for new mineral resulting in the connectivity of trabecular-like architecture (45).

However, in another study  the nano-hydroxyapatite alone  resulted in significantly higher  bone regeneration than the grafting with the combination of silk-fibroin and nano-hydroxyapatite (46). In New Zealand calvarial defects of white rabbits treated with  nano-hydroxyapatite showed 40.16% ± 8.27% new bone formation compared to 16.62% ± 3.05% in the hydroxyapatite graft with silk fibroin scaffold (46). Additionally in the same study, even the control led to better results, (25.66% ± 10.98%)   than the silk fibroin group (46). Other authors  supported the ideea that the hydroxyapatite/ silk fibroin scaffold could be used with better results  than the hydroxyapatite scaffold alone (47).The composite hydroxyapatite/regenerated silk fibroin scaffold supported a significantly increased alkaline phosphatase activity and cell viability than the hydtoxyapatite scaffold alone (47). Also composite silk scaffolds with nano-hydroxyapatite crystals indicated good results in bone regeneration (21).

Composite bioglass/silk fibroin scaffolds may have future uses in the treatment of the osteoporotic fractures, being able  to support regeneration through sustained release of PDGF-b and BMP-7 incoporated in this composite scaffold (48). The ability for these scaffolds to be degraded over time and initiate bone turnover/remodeling has been shown (48).

Moreover, nanocomposites  of silk nanofibers and  gold nanoparticles were fabricated and the resulting scaffolds led to increased cell size of the human mesenchymal stem cells cultivated on them (49). Composite silk-silica biomaterials for bone regeneration were also fabricated and the addition of silica upregulated  the osteogenic markers bone sialoprotein and collagen type 1 in human mesenchymal stem cells subjected to osteogenic differentiation (50). Human mesenchymal stem cells also adhered, proliferated and differentiated towards osteogenic lineages on composite silk/silica films (50).

2.3 Silk fibroin in  dental applications

Silk-gel material is a promising biomaterial for periodontal and maxillofacial therapies, either as a scaffold for cells or alone as a biomaterial (25). In regenerative dentistry, stem cell-based therapy often requires a scaffold to deliver cells and/or growth factors to the injured site (51). Silk fibroin is a promising biomaterials for tissue engineering as it is non toxic and promotes cell proliferation (51).

Based on the successful use of silk scaffolds in bone tissue engineering, researchers examined their utility for mineralized dental tissue engineering and found that tooth  bud rat cells  seeded onto silk  scaffolds appered to guide mineralized tissue formation of osteodentin (52).

 Human dental stem cells obtained from peridontal ligament were cultured on fibroin films and showed discrete proliferation as well as the mantainance of the level of expression of the mesenchymal stem markers CD73, CD90 or CD105 (51). Moreover the combination of human dental stem cells on fibroin and graphene oxide -bioengineered construct has a strong potential for a future therapeutic use in regenerative dentistry (51).

A novel hierarchical textile structure made of silk fibroin from Bombyx mori was developed for ligament regeneration (31). For this purpose, human periodontal ligament fibroblast were cultured in direct contact  with the silk structure and therefore demonstrated an increased secretion of aggrecan and fibronectin  at 3 and 7 days of culture, and no change in IL-6 and TNF-α secretion (31). Although the study tried to regenerate the anterior cruciate ligament, the positive results of dental ligament fibroblast lead way to future dental ligament regeneration.

Silk fibroin  can be used in implant therapy as a recent (2014) study suggests (53). Silk fibroin from non-mulberry source was immobilized on titanium surface, which led to  improved cell adhesion and differentiation, facilitating a better osteogenesis on orthopedic implants (53). Peri-implant defects can be successfully repaired using silk fibroin powder mixed with Choukroun platelet-rich fibrin (PRF) (54).The study on rabbits concluded that after inserting dental implants and filling the peri-implant defects with silk fibroin powder and Choukroun PRF, the mean new bone formation is statistically significantly higher than the one of the controls (54). Another silk fibroin and 4-hexylresorcinol incorporation membrane was fabricated to fill peri-implant defects and was succesfully used in rabbits (55). The silk fibroin and 4-hexylresorcinol  membrane lead to 18.3 ± 1.9 mm mean bone regeneration, almost double than the control group that showed 9.3 ± 0.9 mm of new bone in the histomorphometric analysis (55). Moreover, premineralized silk scaffold was used as a  substrate for bone marrow stromal cells  to construct tissue-engineered bone for mandibular bony defects in a vrat model (56).

Tissue engineered buccal mucosa was obtained from oral keratinocytes and autologous canine fibroblasts seeded onto silk fibroin matrices (57) and the oral keratinocytes and fibroblasts exhibited good biocompatibility with the silk fibroin matrices  (57). Additionally there were develloped  silk fibroin materials for wound repair in the buccal mucosa (24). Ninety wounds to the bucal mucosa applied to rats  were treated with silk fibroin films and scaffolds. The wound shrinkage was significantly lower as well as the growth of mucosal epithelial cells was enhanced without any local or systemic immunological incompatibility (24).

In summary , silk fibroin is a promising material for future regeneration techniques in medicine. Dentistry may very well profit  a lot  from the different silk  fibroin derived materials  which are in tests nowadays since  a vast majority of  the studies concentrate on the regeneration of the osteo-dental tissues.

Acknowledgements: This  work received financial support through the project “CERO – CAREER PROFILE: ROMANIAN RESEARCH”, contract no. HRD / 159 / 1.5 / S / 135760, financed from the European Social Fund Operational Programme Human Resources Development 2007-2013. 


  1. Meinel L, Betz O, Fajardo R, Hofmann S, Nazarian A, Cory E, Hilbe M, McCool J, Langer R, Vunjak-Novakovic G, Merkle HP, Rechenberg B, Kaplan DL, Kirker-Head C. Silk based biomaterials to heal critical sized femur defects. Bone. 2006;39(4):922-931.
  2. Vepari C, Kaplan DL ,Silk as a Biomaterial. Prog Polym Sci. 2007;32(8-9):991-1007.
  3. Wang X, Wenk E, Matsumoto A, Meinel L, Li C, Kaplan DL. Silk microspheres for encapsulation and controlled release. J Control Release. 2007;117(3):360-370.
  4. Meinel L, Hofmann S, Karageorgiou V, Zichner L, Langer R, Kaplan D, Vunjak-Novakovic G, Engineering cartilage-like tissue using human mesenchymal stem cells and silk protein scaffolds. Biotechnol Bioeng. 2004;88(3):379-391.
  5. Karageorgiou V, Meinel L , Hofmann S, Malhotra A, Volloch V, Kaplan D. Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. J Biomed Mater Res A. 2004;71(3):528-537.
  6. Meinel L, Karageorgiou V, Hofmann S, Fajardo R, Snyder B, Li C, Zichner L, Langer R, Vunjak-Novakovic G, Kaplan DL. Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds. J Biomed Mater Res A. 2004;71(1):25-34.
  7. Hofmann S, Foo CT, Textor M, Vunjak-Novakovic G, Kaplan DL, Merkle HP, Meinel L. Silk fibroin as an organic polymer for controlled drug delivery. J Control Release. 2006;111(1-2):219-227.
  8. Gobin AS, Rhea R, Newman RA, Mathur AB. Silk-fibroin-coated liposomes for long-term and targeted drug delivery. Int J Nanomedicine. 2006;1(1):81-87.
  9. Cheema SK, Gobin AS, Rhea R, Lopez-Berestein G, Newman RA, Mathur AB. Silk fibroin mediated delivery of liposomal emodin to breast cancer cells. Int J Pharm. 2007;341(1-2):221-229.
  10. Li L, Puhl S, Meinel L, Germershaus O. Silk fibroin layer-by-layer microcapsules for localized gene delivery. Biomaterials. 2014;35(27):7929-7939.
  11. Wenk E, Merkle HP, Meinel L. Silk fibroin as a vehicle for drug delivery applications. J Control Release. 2011;150(2):128-41.
  12. Kasoju N, Bora U. Silk fibroin in tissue engineering. Adv Healthc Mater. 2012;1(4):393-412.
  13. Nazarov R, Jin HJ, Kaplan DL. Porous 3-D scaffolds from regenerated silk fibroin. Biomacromolecules. 2004;5(3):718-726.
  14. Unger RE, Peters K , Wolf M, Motta A, Migliaresi C, Kirkpatrick CJ. Endothelialization of a non-woven silk fibroin net for use in tissue engineering: growth and gene regulation of human endothelial cells. Biomaterials 2004;25(21):5137-5146.
  15. Maraldi T, Riccio M, Resca E, Pisciotta A, La Sala GB, Ferrari A, Bruzzesi G, Motta A, Migliaresi C, Marzona L, De Pol A. Human amniotic fluid stem cells seeded in fibroin scaffold produce in vivo mineralized matrix. Tissue Eng Part A. 2011;17(21-22):2833-2843.
  16. Saha S, Kundu B, Kirkham J, Wood D, Kundu SC, Yang XB. Osteochondral tissue engineering in vivo: a comparative study using layered silk fibroin scaffolds from mulberry and nonmulberry silkworms. PLoS One. 2013;8(11):e80004.
  17. Min BM, Jeong L, Lee KY, Park WH. Regenerated silk fibroin nanofibers: water vapor-induced structural changes and their effects on the behavior of normal human cells,Macromol Biosci 2006;6(4):285-292.
  18. Min BM, Jeong L,Nam YS, Kim JM, Kim JY, Park WH. Formation of silk fibroin matrices with different texture and its cellular response to normal human keratinocytes Int J Biol Macromol. 2004;34(5):281-288.
  19. Min BM, Lee G , Kim SH, Nam YS, Lee TS, Park WH. Electrospinning of silk fibroin nanofibers and its effect on the adhesion and spreading of normal human keratinocytes and fibroblasts in vitro. Biomaterials. 2004;25(7-8):1289-1297.
  20. Yoo CR, Yeo IS, Park KE, Park JH, Lee SJ, Park WH, Min BM. Effect of chitin/silk fibroin nanofibrous bicomponent structures on interaction with human epidermal keratinocytes. Int J Biol Macromol. 2008;42(4):324-334.
  21. Zhao Y, Chen J , Chou AH, Li G, LeGeros RZ. Nonwoven silk fibroin net/nano-hydroxyapatite scaffold: preparation and characterization. J Biomed Mater Res A. 2009;91(4):1140-1149.
  22. Wang J, Zhou W , Hu W, Zhou L, Wang S, Zhang S. Collagen/silk fibroin bi-template induced biomimetic bone-like substitutes. J Biomed Mater Res A. 2011;99(3):327-334.
  23. Panilaitis B, Altman GH, Chen J, Jin HJ, Karageorgiou V, Kaplan DL. Macrophage responses to silk. Biomaterials. 2003;24(18):3079-3085.
  24. Ge Z, Yang Q , Xiang X, Liu KZ. Assessment of silk fibroin for the repair of buccal mucosa in a rat model. Int J Oral Maxillofac Surg. 2012;41(5):673-680.
  25. Etienne O, Schneider A , Kluge JA, Bellemin-Laponnaz C, Polidori C, Leisk GG, Kaplan DL, Garlick JA, Egles C. Soft tissue augmentation using silk gels: an in vitro and in vivo study. J Periodontol. 2009;80(11):1852-1858.
  26. Kim KH , Jeong L , Park HN, Shin SY, Park WH, Lee SC, Kim TI, Park YJ, Seol YJ, Lee YM, Ku Y, Rhyu IC, Han SB, Chung CP. Biological efficacy of silk fibroin nanofiber membranes for guided bone regeneration. J Biotechnol. 2005;21;120(3):327-339.
  27. Park SY, Ki CS, Park YH, Lee KG, Kang SW, Kweon HY, Kim HJ. Functional recovery guided by an electrospun silk fibroin conduit after sciatic nerve injury in rats. J Tissue Eng Regen Med. 2012;Oct 22.
  28. Higa K, Shimazaki J . Recent advances in cultivated epithelial transplantation. Cornea. 2008;27 Suppl 1:S41-47.
  29. Okabayashi R, Nakamura M, Okabayashi T, Tanaka Y, Nagai A, Yamashita K. Efficacy of polarized hydroxyapatite and silk fibroin composite dressing gel on epidermal recovery from full-thickness skin wound. J Biomed Mater Res B Appl Biomater. 2009;90(2):641-646.
  30. Nakamura M, Soya T , Hiratai R, Nagai A, Hashimoto K, Morita I, Yamashita K. Endothelial cell migration and morphogenesis on silk fibroin scaffolds containing hydroxyapatite electret. J Biomed Mater Res A. 2012;100(4):969-977.
  31. Farè S , Torricelli P , Giavaresi G, Bertoldi S, Alessandrino A, Villa T, Fini M, Tanzi MC, Freddi G. In vitro study on silk fibroin textile structure for anterior cruciate ligament regeneration. Mater Sci Eng C Mater Biol Appl. 2013;33(7):3601-3608.
  32. Teh TK, Toh SL , Goh JC. Aligned hybrid silk scaffold for enhanced differentiation of mesenchymal stem cells into ligament fibroblasts. Tissue Eng Part C Methods. 2011;17(6):687-703.
  33. Park SY, Ki CS , Park YH, Jung HM, Woo KM, Kim HJ. Electrospun silk fibroin scaffolds with macropores for bone regeneration: an in vitro and in vivo study. Tissue Eng Part A. 2010;16(4):1271-1279.
  34. Fini M, Motta A , Torricelli P, Giavaresi G, Nicoli Aldini N, Tschon M, Giardino R, Migliaresi C. The healing of confined critical size cancellous defects in the presence of silk fibroin hydrogel. Biomaterials. 2005;26(17):3527-3536.
  35. Song JY , Kim SG , Lee JW, Chae WS, Kweon H, Jo YY, Lee KG, Lee YC, Choi JY, Kim JY. Accelerated healing with the use of a silk fibroin membrane for the guided bone regeneration technique. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112(6):26-33.
  36. Lee EH, Kim JY, Kweon HY, Jo YY, Min SK, Park YW, Choi JY, Kim SG. A combination graft of low-molecular-weight silk fibroin with Choukroun platelet-rich fibrin for rabbit calvarial defect. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;109(5):e33-38.
  37. Kim JY, Choi JY , Jeong JH, Jang ES, Kim AS, Kim SG, Kweon HY, Jo YY, Yeo JH. Low molecular weight silk fibroin increases alkaline phosphatase and type I collagen expression in MG63 cells. BMB Rep. 2010;43(1):52-56.
  38. Correia C,Grayson W , Eton R, Gimble JM, Sousa RA, Reis RL, Vunjak-Novakovic G. Human adipose-derived cells can serve as a single-cell source for the in vitro cultivation of vascularized bone grafts. J Tissue Eng Regen Med. 2014;8(8):629-639.
  39. Uchida R, Bhawal UK , Kiba H, Arai K, Tanimoto Y, Kuboyama N, Asakura T, Nishiyama N. Effect of plasma-irradiated silk fibroin in bone regeneration. J Biosci Bioeng. 2014;118(3):333-340.
  40. Mobini S, Hoyer B , Solati-Hashjin M, Lode A, Nosoudi N, Samadikuchaksaraei A, Gelinsky M. Fabrication and characterization of regenerated silk scaffolds reinforced with natural silk fibers for bone tissue engineering. J Biomed Mater Res A. 2013;101(8):2392-2404.
  41. Thimm BW , Wüst S , Hofmann S, Hagenmüller H, Müller R. Initial cell pre-cultivation can maximize ECM mineralization by human mesenchymal stem cells on silk fibroin scaffolds. Acta Biomater. 2011;7(5):2218-2228.
  42. Riccio M, Maraldi T , Pisciotta A, La Sala GB, Ferrari A, Bruzzesi G, Motta A, Migliaresi C, De Pol A. Fibroin scaffold repairs critical-size bone defects in vivo supported by human amniotic fluid and dental pulp stem cells. Tissue Eng Part A. 2012;18(9-10):1006-1013.
  43. Meinel L, Fajardo R, Hofmann S, Langer R, Chen J, Snyder B, Vunjak-Novakovic G, Kaplan D. Silk implants for the healing of critical size bone defects. Bone. 2005;37(5):688-698.
  44. Zhao J, Zhang Z, Wang S, Sun X, Zhang X, Chen J, Kaplan DL, Jiang X. Apatite-coated silk fibroin scaffolds to healing mandibular border defects in canines. Bone. 2009;45(3):517-527.
  45. Bhumiratana S, Grayson WL, Castaneda A, Rockwood DN, Gil ES, Kaplan DL, Vunjak-Novakovic G. Nucleation and growth of mineralized bone matrix on silk-hydroxyapatite composite scaffolds. Biomaterials. 2011;32(11):2812-2820.
  46. Kweon H, Lee KG, Chae CH, Balázsi C, Min SK, Kim JY, Choi JY, Kim SG. Development of nano-hydroxyapatite graft with silk fibroin scaffold as a new bone substitute. J Oral Maxillofac Surg. 2011;69(6):1578-1586.
  47. Jiang J, Hao W, Li Y, Yao J, Shao Z, Li H, Yang J, Chen S. Hydroxyapatite/regenerated silk fibroin scaffold-enhanced osteoinductivity and osteoconductivity of bone marrow-derived mesenchymal stromal cells. Biotechnol Lett. 2013;35(4):657-661.
  48. Zhang Y, Zhang Z, Miron R, Shi B, Cheng X. Delivery of PDGF-B and BMP-7 by mesoporous bioglass/silk fibrin scaffolds for the repair of osteoporotic defects. Biomaterials. 2012;33(28):6698-6708.
  49. Cohen-Karni T, Jeong KJ , Tsui JH, Reznor G, Mustata M, Wanunu M, Graham A, Marks C, Bell DC, Langer R, Kohane DS. Nanocomposite gold-silk nanofibers. Nano Lett. 2012;12(10):5403-5406.
  50. Mieszawska AJ, Fourligas N, Georgakoudi I, Ouhib NM, Belton DJ, Perry CC, Kaplan DL. Osteoinductive silk-silica composite biomaterials for bone regeneration. Biomaterials. 2010;31(34):8902-8910.
  51. Rodríguez-Lozano FJ, García-Bernal D, Aznar-Cervantes S, Ros-Roca MA, Algueró MC, Atucha NM, Lozano-García AA, Moraleda JM, Cenis JL. Effects of composite films of silk fibroin and graphene oxide on the proliferation, cell viability and mesenchymal phenotype of periodontal ligament stem cells. J Mater Sci Mater Med. 2014 Aug 1.
  52. Xu WP, Zhang W , Asrican R, Kim HJ, Kaplan DL, Yelick PC. Accurately shaped tooth bud cell-derived mineralized tissue formation on silk scaffolds. Tissue Eng Part A. 2008;14(4):549-557.
  53. Naskar D, Nayak S, Dey T, Kundu SC. Non-mulberry silk fibroin influence osteogenesis and osteoblast-macrophage cross talk on titanium based surface. Sci Rep 2014;4:4745.
  54. Jang ES, Park JW, Kweon H, Lee KG, Kang SW, Baek DH, Choi JY, Kim SG. Restoration of peri-implant defects in immediate implant installations by Choukroun platelet-rich fibrin and silk fibroin powder combination graft. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;109(6):831-836.
  55. Lee SW, Kim SG, Song JY, Kweon H, Jo YY, Lee KG, Kang SW, Yang BE. Silk fibroin and 4-hexylresorcinol incorporation membrane for guided bone regeneration. J Craniofac Surg 2013;24(6):1927-1930.
  56. Jiang X, Zhao J, Wang S, Sun X, Zhang X, Chen J, Kaplan DL, Zhang Z. Mandibular repair in rats with premineralized silk scaffolds and BMP-2-modified bMSCs. Biomaterials. 2009;30(27):4522-4532.
  57. Xie M, Xu Y, Song L, Wang J, Lv X, Zhang Y. Tissue-engineered buccal mucosa using silk fibroin matrices for urethral reconstruction in a canine model. J Surg Res. 2014;188(1):1-7.